✦ LIBER ✦

An open-label study to evaluate dose and cycle dependence of the pharmacokinetics of pegylated liposomal doxorubicin

✍ Scribed by Alberto Gabizon; Rut Isacson; Ora Rosengarten; Dina Tzemach; Hilary Shmeeda; Rama Sapir

Publisher: Springer
Year: 2007
Tongue: English
Weight: 459 KB
Volume: 61
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-007-0525-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of liposomal doxorubici

Pharmacokinetics of liposomal doxorubicin (TLC-D99; Myocet) in patients with solid tumors: an open-label, single-dose study

✍ Klaus Mross; Bernward Niemann; Ulrich Massing; Joachim Drevs; Clemens Unger; Rup 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 356 KB

A multicenter, open-label, dose-ranging

A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis

✍ Kiwamu Okita; Isao Sakaida; Mitsuru Okada; Akira Kaneko; Kazuaki Chayama; Michio 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 329 KB

A randomized, open-label study to evalua

A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients

✍ Gary L. Davis; David R. Nelson; Norah Terrault; Timothy L. Pruett; Thomas D. Sch 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

## Collaborative Antiviral Study Group Chronic hepatitis C is the most common indication for liver transplantation, but viral recurrence is universal and progressive graft injury occurs in most recipients. Our aim was to assess the safety, pharmacokinetics (PK), and antiviral effects of high doses

Erratum to: A multicenter, open-label, d

Erratum to: A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis

✍ Kiwamu Okita; Isao Sakaida; Mitsuru Okada; Akira Kaneko; Kazuaki Chayama; Michio 📂 Article 📅 2010 🏛 Springer Japan 🌐 English ⚖ 75 KB

Open-label flexible-dose pilot study to

Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease

✍ Joseph H. Friedman; Robert M. Berman; Christopher G. Goetz; Stewart A. Factor; W 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB 👁 2 views

## Abstract Psychosis affects at least 5% to 8% of medication‐treated patients with idiopathic Parkinson's disease (PD). Treatment options include reducing medications used for the treatment of PD‐related motor symptoms or introducing an atypical antipsychotic drug. Only clozapine has been demonstr

An open study to compare the pharmacokin

An open study to compare the pharmacokinetics, safety and tolerability of a multiple-dose regimen of azithromycin in young and elderly volunteers

✍ P. Coates; R. Daniel; A. C. Houston; J. H. L. Antrobus; T. Taylor 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 375 KB